Topical Application of Hangeshashinto (TJ-14) in the Treatment of Chemotherapy-Induced Oral Mucositis

scientific article published in December 2010

Topical Application of Hangeshashinto (TJ-14) in the Treatment of Chemotherapy-Induced Oral Mucositis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4021/WJON263W
P8608Fatcat IDrelease_yjqoahkw7fgbbpnavde6liy6fm
P932PMC publication ID5649748
P698PubMed publication ID29147213
P5875ResearchGate publication ID270087732

P2093author name stringHidenori Karasaki
Toru Kono
Naoyuki Chisato
Toshiyuki Asama
Yoshiaki Ebisawa
Hiroyuki Furukawa
Kazuo Matsubara
Machiko Satomi
Manabu Suno
P2860cites workRole of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot studyQ34553968
Pathobiology of mucositisQ35707055
The pathobiology of mucositisQ35730297
Anti-inflammatory agents in the management of alimentary mucositisQ36432423
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancerQ36443643
Quaternary protoberberine alkaloids.Q36655345
Oral mucositis: review of pathogenesis, diagnosis, prevention, and managementQ36903556
Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking groupQ37381086
Exodus of Kampo, traditional Japanese medicine, from the complementary and alternative medicines: is it time yet?Q37594963
Oral mucositis. Review of literature.Q37722722
Monocyte membrane type 1-matrix metalloproteinase. Prostaglandin-dependent regulation and role in metalloproteinase-2 activationQ43548143
The effects of Hange-shashin-to on the content of prostaglandin E2 and water absorption in the large intestine of ratsQ73792312
Mechanisms by which Hange-shashin-to reduces prostaglandin E2 levelsQ77768417
Oral mucositisQ83343556
P433issue6
P304page(s)232-235
P577publication date2010-12-01
P1433published inWorld journal of oncologyQ27723779
P1476titleTopical Application of Hangeshashinto (TJ-14) in the Treatment of Chemotherapy-Induced Oral Mucositis
P478volume1

Reverse relations

cites work (P2860)
Q52316719A Review of Evidence for a Therapeutic Application of Traditional Japanese Kampo Medicine for Oral Diseases/Disorders.
Q35835142Analysis of the antioxidative function of the radioprotective Japanese traditional (Kampo) medicine, hangeshashinto, in an aqueous phase
Q37724518Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis
Q40741520Effects of Hangeshashinto on Growth of Oral Microorganisms.
Q47155332Efficacy of Banha-sasim-tang on functional dyspepsia classified as excess pattern: study protocol for a randomized controlled trial
Q35066654Herbal medicines for the treatment of cancer chemotherapy-induced side effects
Q92751411How to bridge the gap? European medical plants used for treating oral mucositis: on the search for evidence
Q60961916Kampo (Traditional Japanese Herbal) Formulae for Treatment of Stomatitis and Oral Mucositis
Q34497892Preventive effect of Daiokanzoto (TJ-84) on 5-fluorouracil-induced human gingival cell death through the inhibition of reactive oxygen species production
Q47102325Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer
Q93075558The Biological Efficacy of Natural Products against Acute and Chronic Inflammatory Diseases in the Oral Region
Q92740178The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis
Q98945639The effect of Hangeshashinto on Oral Mucositis Caused by Induction Chemotherapy in Patients with Head and Neck Cancer
Q26785314Traditional Japanese herbal medicines for treatment of odontopathy